Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia

MLA

Hilary A. Tindle, et al. “Design of a Randomized Controlled Trial of Smoking Cessation Medications for Alcohol Reduction among HIV-Positive Heavy Drinkers and Daily Smokers in St. Petersburg, Russia.” Contemporary Clinical Trials Communications, vol. 19, no. 100625-, Sept. 2020. EBSCOhost, https://doi.org/10.1016/j.conctc.2020.100625.

APA

Hilary A. Tindle, Matthew S. Freiberg, Natalia Gnatienko, Elena Blokhina, Debbie M. Cheng, Tatiana Yaroslavtseva, Sally Bendiks, Michael Winter, Evgeny Krupitsky, & Jeffrey H. Samet. (2020). Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia. Contemporary Clinical Trials Communications, 19(100625-). https://doi.org/10.1016/j.conctc.2020.100625

Chicago

Hilary A. Tindle, Matthew S. Freiberg, Natalia Gnatienko, Elena Blokhina, Debbie M. Cheng, Tatiana Yaroslavtseva, Sally Bendiks, Michael Winter, Evgeny Krupitsky, and Jeffrey H. Samet. 2020. “Design of a Randomized Controlled Trial of Smoking Cessation Medications for Alcohol Reduction among HIV-Positive Heavy Drinkers and Daily Smokers in St. Petersburg, Russia.” Contemporary Clinical Trials Communications 19 (100625-). doi:10.1016/j.conctc.2020.100625.